Friday, July 10, 2026

pharma · Immunotherapy · Opioid Analgesic Adverse Reaction

Second Affiliated Hospital

Second Affiliated Hospital trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
103 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Employees
103
Programs
4
Drugs
11
Patents
0
Intelligence · Clinical Trials

Second Affiliated Hospital clinical trials

Registry index of 4 ClinicalTrials.gov studies linked to Second Affiliated Hospital programs — each row shows trial ID, program name, phase, status, and indication.

Second Affiliated Hospital trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for Second Affiliated Hospital.

  1. ZZ-IT-ICI-HCC 1line-023 — Phase 2

    Clinical update
  2. Esketamine, Sulfentanil or/and Remifentanil — Unknown

    Clinical update
  3. Cadonilimab — Phase 2

    Clinical update
  4. Vedolizumab — Approved

    Clinical update

Trial registry

4 studies